Does tadalafil make you last longer in bed? This is a frequently asked question, but it's important to understand what tadalafil actually does. Tadalafil is a prescription medication licensed in the UK for treating erectile dysfunction (ED) and benign prostatic hyperplasia. It works by enhancing blood flow to the penis, helping men achieve and maintain an erection during sexual activity. However, tadalafil is not designed to delay ejaculation or treat premature ejaculation. This article explains how tadalafil works, its appropriate uses, and the key differences between erectile dysfunction and premature ejaculation, helping you make informed decisions about your sexual health.

What Is Tadalafil and How Does It Work?

Tadalafil is a prescription medication licensed in the UK for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) in adult men. It belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which also includes sildenafil (Viagra) and vardenafil. Tadalafil is available under brand names such as Cialis, as well as generic formulations approved by the Medicines and Healthcare products Regulatory Agency (MHRA).

The mechanism of action centres on the enzyme PDE5, which is found in the smooth muscle of the corpus cavernosum in the penis. During sexual arousal, nitric oxide is released in penile tissue, which activates an enzyme called guanylate cyclase. This leads to increased levels of cyclic guanosine monophosphate (cGMP), a chemical messenger that relaxes smooth muscle and allows blood to flow into the penis, producing an erection. PDE5 normally breaks down cGMP, limiting the duration of the erection.

Tadalafil works by inhibiting PDE5, thereby preventing the breakdown of cGMP and allowing it to accumulate. This results in prolonged smooth muscle relaxation and enhanced blood flow to the penis when sexual stimulation occurs. It is important to note that tadalafil does not cause an erection on its own—sexual arousal is still required for the medication to be effective.

Tadalafil is notable for its long duration of action, with effects lasting up to 36 hours in some individuals. This distinguishes it from shorter-acting PDE5 inhibitors and has led to its popularity for both on-demand and daily low-dose regimens. The MHRA-approved indications are specifically for erectile dysfunction and symptoms of BPH, not for other sexual performance concerns.

Note that tadalafil is also available under a different brand name for pulmonary arterial hypertension, but this use is outside the scope of this article.

How to Use Tadalafil Safely and Effectively

Tadalafil is available in the UK in several dosing regimens, and the appropriate choice depends on individual circumstances and clinical assessment. For on-demand use in erectile dysfunction, the typical starting dose is 10 mg taken at least 30 minutes before anticipated sexual activity. Depending on efficacy and tolerability, this may be increased to 20 mg or reduced to 5 mg. The medication can be taken with or without food, as food does not significantly affect its absorption.

For men who anticipate sexual activity more than twice weekly, a daily low-dose regimen of 2.5 mg or 5 mg may be more suitable. This approach allows for spontaneity, as the medication maintains steady plasma levels. NICE guidance supports both regimens as clinically appropriate options, with the choice guided by patient preference and lifestyle factors.

Important safety considerations include:

• Tadalafil should not be taken more than once daily, regardless of the dose.

• Contraindications: Tadalafil must not be used with nitrates (e.g., glyceryl trinitrate for angina) or guanylate cyclase stimulators such as riociguat, as these combinations can cause severe, potentially life-threatening hypotension. Sexual activity is inadvisable for men with certain cardiovascular conditions, including unstable angina, severe heart failure, or recent (within 90 days) myocardial infarction or stroke (within 6 months).

• Drug interactions: Caution is required with alpha-blockers (used for BPH or hypertension), as concurrent use may increase the risk of postural hypotension. Patients should be stable on alpha-blocker therapy before starting tadalafil, and doxazosin combinations require particular caution. CYP3A4 inhibitors such as ritonavir, ketoconazole, and erythromycin can increase tadalafil levels, necessitating dose adjustment. CYP3A4 inducers (e.g., rifampicin, carbamazepine) may reduce tadalafil effectiveness. Grapefruit juice should be avoided as it may increase tadalafil levels.

• Dose adjustments: Lower doses may be needed in older adults and those with renal or hepatic impairment. Tadalafil is not recommended in severe renal or hepatic impairment.

• Adverse effects: Common side effects include headache, dyspepsia, back pain, myalgia, nasal congestion, and flushing. These are generally mild and transient.

Patients should be advised to seek urgent medical attention if they experience an erection lasting more than four hours (priapism), sudden vision or hearing loss, or chest pain during sexual activity. If chest pain occurs after taking tadalafil, do not use nitrates and inform emergency healthcare providers about the tadalafil use. Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme.

Tadalafil should only be obtained through legitimate UK-registered pharmacies following appropriate medical assessment.

Does Tadalafil Help You Last Longer During Sex?

This is a common question, but it is important to clarify what tadalafil does and does not do. Tadalafil is licensed specifically for erectile dysfunction—it helps men achieve and maintain an erection sufficient for sexual intercourse. It does this by enhancing blood flow to the penis in response to sexual stimulation. However, there is no official evidence that tadalafil delays ejaculation or directly increases the time to ejaculation (ejaculatory latency).

The confusion often arises because improved erectile function may indirectly influence sexual duration. Men with ED who regain confidence and erectile rigidity may feel they perform better overall, and this psychological benefit can contribute to a more satisfying sexual experience. Some men report that the ability to achieve a second erection more quickly after ejaculation (reduced refractory period) allows for prolonged sexual activity, though this effect is anecdotal, variable, and not guaranteed. However, this is not the same as delaying ejaculation itself.

Premature ejaculation (PE) is a distinct condition characterised by ejaculation that occurs sooner than desired, often within one minute of penetration for lifelong PE (or approximately three minutes or less for acquired PE), and causes distress. The underlying mechanisms of PE involve serotonin pathways and ejaculatory reflex control, which are not directly affected by PDE5 inhibitors like tadalafil. For men with PE, the European Association of Urology (EAU) recommends dapoxetine as a first-line on-demand pharmacological treatment. NICE Clinical Knowledge Summaries (CKS) support dapoxetine as an option for suitable men with PE.

Some studies have explored combination therapy (tadalafil plus dapoxetine or SSRIs) in men with both ED and PE, with mixed results. While there may be modest benefits in selected cases, this is not standard practice and should only be considered under specialist guidance. Patients concerned about ejaculatory control should discuss this explicitly with their GP or a sexual health specialist, as the appropriate treatment differs significantly from that for ED.

Tadalafil for Erectile Dysfunction vs Premature Ejaculation

Understanding the distinction between erectile dysfunction and premature ejaculation is essential for appropriate treatment. Erectile dysfunction is the persistent inability to achieve or maintain an erection adequate for satisfactory sexual performance. It is often related to vascular, neurological, hormonal, or psychological factors, and prevalence increases with age and comorbidities such as diabetes, hypertension, and cardiovascular disease. Tadalafil addresses ED by improving penile blood flow and is supported by robust evidence from randomised controlled trials and real-world data.

ED may also be an early marker of cardiovascular disease, so assessment should include blood pressure measurement, lipid profile, blood glucose or HbA1c testing, and lifestyle review. Morning testosterone levels may be checked if hypogonadism is suspected.

Premature ejaculation, by contrast, involves poor ejaculatory control and is classified into lifelong (primary) and acquired (secondary) subtypes. Lifelong PE typically involves ejaculation within about one minute of penetration, while acquired PE often occurs within approximately three minutes. The pathophysiology is thought to involve altered serotonin neurotransmission and heightened penile sensitivity. PE is not caused by inadequate blood flow, so PDE5 inhibitors like tadalafil do not target the underlying mechanism. The recommended treatments for PE include:

• Behavioural techniques: The stop-start method and squeeze technique can help improve ejaculatory control.

• Topical anaesthetics: Fortacin (lidocaine/prilocaine) spray is licensed in the UK for PE. Other topical anaesthetics like EMLA cream may be used off-label.

• Dapoxetine: A short-acting SSRI taken on demand, licensed specifically for PE in the UK.

• Off-label SSRIs: Daily paroxetine, sertraline, or fluoxetine may be considered, though this is outside their licensed indication.

Some men experience both ED and PE concurrently, which can complicate management. In such cases, addressing the ED first with tadalafil may improve confidence and reduce performance anxiety, which can secondarily benefit ejaculatory control. However, if PE persists, additional targeted therapy is warranted.

Patients should consult their GP or a specialist in sexual medicine for a thorough assessment. Referral to specialist services may be appropriate for severe psychological distress, complex comorbidities, or when first-line treatments are ineffective. Self-diagnosis and use of unregulated online sources carry significant risks, including counterfeit medications and inappropriate treatment. A holistic approach that considers psychological factors, relationship dynamics, and underlying health conditions is essential for optimal outcomes. NICE and the British Society for Sexual Medicine provide evidence-based guidelines to support clinicians in delivering individualised care.

Frequently Asked Questions